Apogee Therapeutics Set to Attend Upcoming Conferences

Upcoming Investor Conferences: Apogee Therapeutics will participate in several investor conferences in November and December 2025, including the Guggenheim Healthcare Innovation Conference and the Citi Global Healthcare Conference, featuring fireside chats at scheduled times.

Company Overview: Apogee Therapeutics is a clinical-stage biotechnology company focused on developing novel biologics for inflammatory and immune conditions, with a particular emphasis on treatments for Atopic Dermatitis, asthma, and other related diseases.

Advanced Programs: The company's lead program, APG777, targets Atopic Dermatitis, aiming to provide best-in-class treatment options by utilizing advanced antibody engineering to enhance therapeutic efficacy and patient outcomes.

Commitment to Innovation: Apogee Therapeutics is dedicated to addressing unmet medical needs in the I&I market by leveraging its expertise and broad pipeline to deliver innovative therapies that improve patient care.